Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 50.90
+0.59 (1.17%)
At close: Feb 27, 2026
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 23.38 billion as of February 27, 2026. Its market cap has increased by 34.25% in one year.
Market Cap
23.38B
Enterprise Value
22.51B
Revenue
607.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.90
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 23.38B, an increase of 42.19%. That is a compound annual growth rate of 8.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 23.38B | -12.00% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Livzon Pharmaceutical Group | 28.60B |
| Chengdu Kanghong Pharmaceutical Group | 26.55B |
| Kangmei Pharmaceutical | 26.41B |
| Hubei Jumpcan Pharmaceutical | 25.29B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 24.06B |
| Zhejiang Huahai Pharmaceutical | 23.86B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 22.73B |
| Tasly Pharmaceutical Group | 21.93B |